1. Mayer NH, Herman RM. Positive signs and consequences of an upper motor neuron syndrome. In: Brashear A, Mayer NH, editors. Spasticity and other forms of muscle overactivity in the upper motor neuron syndrome: etiology. Evaluation: Management and the role of botulinum toxin. We move; 2008. p. 11–26.
2. Nance PW, Satkunam L, Ethans K. Spasticity management. In: Braddom RL, Chan L, Harrast MA, Kowalske KJ, Matthews DJ, Rangarsson KT, Stolp KA, editors. Physical medicine & rehabilitation. Philadelphia: Elsevier Saunders; 2011. p. 641–59.
3. Satkunam LE. Rehabilitation medicine: management of adult spascitity. CMAJ. 2003;169:1173–9.
4. Mayer NH, Esquenazi A, Childers MK. Common patterns of clinical motor dysfunction. In: Brashear A, Mayer NH, editors. Spasticity and other forms of muscle overactivity in the upper motor neuron syndrome: etiology. Evaluation: Management and the Role of Botulinum Toxin. We Move; 2008. p. 26–38.
5. Gracies JM. Pathophysiology of impairment in patients with spasticity and use of stretch as a treatment of spastic hypertonia. Phys Med Rehabil Clin N Am. 2001;12(4):747–68.